TMLHE


Description

The TMLHE (trimethyllysine hydroxylase, epsilon) is a protein-coding gene located on chromosome X.

The TMLHE gene, located on chromosome X, encodes a mitochondrial enzyme called trimethyllysine dioxygenase. This enzyme plays a critical role in carnitine biosynthesis, a pathway essential for the transport of fatty acids within cells. Mutations in the TMLHE gene can lead to carnitine biosynthesis disruption, which has been linked to autism symptoms.

Structure: TMLHE is located in the mitochondrial matrix, where it acts as a non-heme-ferrous iron hydrolase.

Function: TMLHE catalyzes the first step in the carnitine biosynthesis pathway, converting trimethyllysine (TML) into hydroxytrimethyllysine (HTML). This conversion requires iron and L-ascorbate as cofactors.

Clinical Significance: Mutations in the TMLHE gene can cause epsilon-trimethyllysine hydroxylase deficiency (TMLHED), an inborn error of metabolism affecting carnitine biosynthesis. This deficiency can increase the risk of neurodevelopmental disorders, autism-related behaviors, and autism spectrum disorders.

Interactions: TMLHE is known to interact with 14 other proteins, including 12 co-complex interactions.

TMLHE is also known as AUTSX6, BBOX2, TMLD, TMLH, TMLHED, XAP130.

Associated Diseases


Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.